TASIGNA
Live / Registered — Registered — Section 71 accepted (as of 28 Mar 2019)
What this means for you
Registered since 09 Jun 2009. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79062925
- Registration number
- 3635627
- Mark type
- Stylized text
- Filed
- 07 Aug 2008
- Published for opposition
- 24 Mar 2009
- Registered
- 09 Jun 2009
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- Novartis AG, Basel, CH
- Novartis AG, CH
- Novartis AG, CH
Prior registrations
Prosecution history
- 25 Apr 2024 — INTERNATIONAL REGISTRATION RENEWED
- 28 Mar 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Mar 2019 — REGISTERED-SEC.71 ACCEPTED
- 19 Mar 2019 — TEAS SECTION 71 RECEIVED
- 09 Jun 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 11 Jun 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 11 Jun 2015 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 11 Jun 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 May 2015 — TEAS SECTION 71 & 15 RECEIVED
- 18 Sept 2014 — INTERNATIONAL REGISTRATION RENEWED
- 12 Apr 2013 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Feb 2013 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 11 Dec 2009 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Sept 2009 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Sept 2009 — FINAL DISPOSITION PROCESSED